p.66 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

June 11, 2024 Circulation. 2024;149:e1313–e1410. DOI: 10.1161/CIR.0000000000001251 e1378

PRESIDENTS AND STAFF

American College of Cardiology Cathleen Biga, MSN, FACC, President Cathleen C. Gates, Chief Executive Officer Richard J. Kovacs, MD, MACC, Chief Medical Officer Mindy J. Saraco, MHA, Director, Clinical Policy and Guidelines Grace D. Ronan, Senior Production and Operations Manager, Clinical Policy Publications Leah Patterson, Project Manager, Clinical Content

Development American Heart Association/American College of Cardiology Abdul R. Abdullah, MD, National Director, Guideline Science and Methodology Shae Martinez, MLS, Reference Consultant, Medical

Librarian American Heart Association

Joseph C. Wu, MD, PhD, FAHA, President Nancy Brown, Chief Executive Officer Mariell Jessup, MD, FAHA, Chief Science and Medical Officer Nicole Aiello Sapio, EdD, Executive Vice President, Office of Science Strategies and Operations Radhika Rajgopal Singh, PhD, Senior Vice President, Office of Science and Medicine Prashant Nedungadi, BPharm, PhD, Vice President, Science and Medicine, Clinical Guidelines Barbara Entl, MD, Science and Medicine Advisor, Science, Medicine and Health Jody Hundley, Senior Production and Operations

Manager, Scientific Publications, Office of Science Operations

ARTICLE INFORMATION This document was approved by the American College of Cardiology Clinical Policy Approval Committee in December 2023, the American Heart Association Science Advisory and Coordinating Committee in January 2024, and the American College of Cardiology Science and Quality Committee and the American Heart Association Executive Committee in February 2024. Supplemental materials are available with this article at https://www. ahajournals.org/doi/suppl/10.1161/CIR.0000000000001251 This article has been copublished in the Journal of the American College of Cardiology. Copies: This document is available on the websites of the American Heart Association (professional.heart.org) and the American College of Cardiology (www. acc.org). A copy of the document is also available at https://professional.heart.org/ statements by selecting the “Guidelines & Statements” button. To purchase additional reprints, call 215-356-2721 or email Meredith.Edelman@wolterskluwer.com. The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit https://professional.heart.org/statements. Select the “Guidelines & Statements” drop-down menu near the top of the webpage, then click “Publication Development.” Permissions: Multiple copies, modification, alteration, enhancement, and distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at https://www.heart.org/permissions. A link to the “Copyright Permissions Request Form” appears in the second paragraph (https://www.heart.org/en/about-us/ statements-and-policies/copyright-request-form).

REFERENCES Preamble 1.	 Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (US). Clinical Practice Guidelines We Can Trust. National Academies Press; 2011. 2.	 Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011. 3.	 Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA statement on

cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation. 2014;129:2329–2345. 4 ACCF/AHA Task Force on Practice Guidelines. Methodology Manual

and Policies from the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Accessed November 5, 2021. https://professional.heart.org/-/media/ PHD-Files/Guidelines-and-Statements/methodology_manual_and_ policies_ucm_319826.pdf. 5.	 Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133:1426–1428. 6.	 Arnett DK, Goodman RA, Halperin JL, et al. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. Circulation. 2014;130:1662–1667. 7.	 Levine GN, O’Gara PT, Beckman JA, et al. Recent innovations, modifications,

and evolution of ACC/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e879–e886. 1.4. Scope of the Guideline 1.	 Allison MA, Ho E, Denenberg JO, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32:328– 333. 2.	 Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145:e153–e639. 3.	 Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020–e1030. 4.	 Eid MA, Mehta K, Barnes JA, et al. The global burden of peripheral artery disease. J Vasc Surg. 2023;77:1119–1126.e1. 5.	 Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726–e779. 6.	 Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278–e333. 7.	 Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused

update on duration of dual antiplatelet therapy in patients with coronary

Downloaded from http://ahajournals.org by on October 7, 2026